Showing results (161-170 of 313) with videos related to

Sort By:
Pageof 32
Obesity (Silver Spring, Md.)|December 26, 2025
Weight Loss With SGLT2 Inhibitors, Semaglutide, and Transcranial Magnetic Stimulation in Type 2 Diabetes and ObesityAnna Ferrulli, Pamela Senesi, Andrea Sonaglioni, et al.
Diabetes, Obesity & Metabolism|August 31, 2019
Hormone-substrate changes with exenatide plus dapagliflozin versus each drug alone: The randomized, active-controlled DURATION-8 studyEle Ferrannini, Simona Baldi, Juan P Frías, et al.
Diabetes|March 21, 2024
Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT SubjectsXi Chen, Devjit Tripathy, Robert Chilton, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 12, 2002
Free fatty acid-induced peripheral insulin resistance augments splanchnic glucose uptake in healthy humansMandeep Bajaj, Rachele Berria, Thongchai Pratipanawatr, et al.
Diabetes|April 22, 2017
Empagliflozin and Kinetics of Renal Glucose Transport in Healthy Individuals and Individuals With Type 2 DiabetesHussein Al-Jobori, Giuseppe Daniele, Eugenio Cersosimo, et al.
American Journal of Physiology. Endocrinology and Metabolism|March 13, 2008
Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetesAntonio Cervera, Estela Wajcberg, Apiradee Sriwijitkamol, et al.
The Journal of Clinical Endocrinology and Metabolism|January 15, 2016
Effect of Dapagliflozin With and Without Acipimox on Insulin Sensitivity and Insulin Secretion in T2DM MalesAurora Merovci, Muhammad Abdul-Ghani, Andrea Mari, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 22, 2008
The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose toleranceMuhammad A Abdul-Ghani, Masafumi Matsuda, Rucha Jani, et al.
Pageof 32